Deborah Gilbert

466 total citations
19 papers, 362 citations indexed

About

Deborah Gilbert is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Deborah Gilbert has authored 19 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pharmacology, 14 papers in Molecular Medicine and 6 papers in Epidemiology. Recurrent topics in Deborah Gilbert's work include Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (14 papers) and Pneumonia and Respiratory Infections (6 papers). Deborah Gilbert is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (18 papers), Antibiotic Resistance in Bacteria (14 papers) and Pneumonia and Respiratory Infections (6 papers). Deborah Gilbert collaborates with scholars based in United States and Russia. Deborah Gilbert's co-authors include Stephen H. Zinner, Michael N. Dudley, Alexander A. Firsov, Antone A. Medeiros, C. Randall Marchbanks, K.L. Greer, Danièle Saverino, N J Robillard, Barbara G. Painter and J. Blaser and has published in prestigious journals such as Genome Research, The American Journal of Medicine and The Journal of Infectious Diseases.

In The Last Decade

Deborah Gilbert

19 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deborah Gilbert United States	12	292	236	100	63	62	19	362
Inga Odenholt-Tornqvist Sweden	8	328 1.1×	247 1.0×	147 1.5×	25 0.4×	62 1.0×	9	436
P. B. Harper United Kingdom	9	195 0.7×	247 1.0×	104 1.0×	31 0.5×	37 0.6×	17	377
Zoi Chryssouli Greece	10	163 0.6×	273 1.2×	109 1.1×	48 0.8×	50 0.8×	15	337
L Xerri Italy	8	205 0.7×	307 1.3×	130 1.3×	58 0.9×	19 0.3×	27	474
Eleftheria Trikka‐Graphakos Greece	8	140 0.5×	210 0.9×	126 1.3×	65 1.0×	43 0.7×	12	347
J Woodcock United Kingdom	5	235 0.8×	185 0.8×	177 1.8×	28 0.4×	39 0.6×	6	377
Martín Bäcker United States	8	129 0.4×	228 1.0×	84 0.8×	60 1.0×	35 0.6×	16	389
Marc Rosen United States	5	339 1.2×	231 1.0×	157 1.6×	39 0.6×	90 1.5×	8	444
R. E. Buck United States	9	318 1.1×	194 0.8×	114 1.1×	30 0.5×	45 0.7×	16	452
Steven Fikes United States	9	198 0.7×	215 0.9×	105 1.1×	65 1.0×	32 0.5×	11	329

Countries citing papers authored by Deborah Gilbert

Since Specialization

Citations

This map shows the geographic impact of Deborah Gilbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Gilbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Gilbert more than expected).

Fields of papers citing papers by Deborah Gilbert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Gilbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Gilbert. The network helps show where Deborah Gilbert may publish in the future.

Co-authorship network of co-authors of Deborah Gilbert

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Gilbert. A scholar is included among the top collaborators of Deborah Gilbert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Gilbert. Deborah Gilbert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Zinner, Stephen H., Deborah Gilbert, K.L. Greer, Yury A. Portnoy, & Alexander A. Firsov. (2012). Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model. Journal of Antimicrobial Chemotherapy. 68(4). 881–887. 15 indexed citations

Firsov, Alexander A., et al.. (2011). Comparative Pharmacodynamics and Antimutant Potentials of Doripenem and Imipenem with Ciprofloxacin-Resistant Pseudomonas aeruginosa in an In Vitro Model. Antimicrobial Agents and Chemotherapy. 56(3). 1223–1228. 8 indexed citations

Zinner, Stephen H., Deborah Gilbert, Irene Yu Lubenko, K.L. Greer, & Alexander A. Firsov. (2008). Selection of linezolid-resistant Enterococcus faecium in an in vitro dynamic model: protective effect of doxycycline. Journal of Antimicrobial Chemotherapy. 61(3). 629–635. 26 indexed citations

Firsov, Alexander A., et al.. (2006). Net Effect of Inoculum Size on Antimicrobial Action of Ampicillin-Sulbactam: Studies Using an In Vitro Dynamic Model. Antimicrobial Agents and Chemotherapy. 50(9). 3230–3230. 2 indexed citations

Firsov, Alexander A., et al.. (2006). Predictors of Effect of Ampicillin-Sulbactam against TEM-1 β-Lactamase-Producing Escherichia coli in an In Vitro Dynamic Model: Enzyme Activity versus MIC. Antimicrobial Agents and Chemotherapy. 50(9). 3229–3229. 18 indexed citations

Zinner, Stephen H., Kelly Simmons, & Deborah Gilbert. (2000). Comparative Activities of Ciprofloxacin and Levofloxacin against Streptococcus pneumoniae in an In Vitro Dynamic Model. Antimicrobial Agents and Chemotherapy. 44(3). 773–774. 7 indexed citations

Gilbert, Deborah, et al.. (1999). The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model. Clinical Microbiology and Infection. 5(1). 12–15. 5 indexed citations

Zinner, Stephen H., Deborah Gilbert, & Michael N. Dudley. (1998). Activity of Trovafloxacin (with or without Ampicillin-Sulbactam) against Enterococci in an In Vitro Dynamic Model of Infection. Antimicrobial Agents and Chemotherapy. 42(1). 72–77. 11 indexed citations

Firsov, Alexander A., et al.. (1997). Net effect of inoculum size on antimicrobial action of ampicillin-sulbactam: studies using an in vitro dynamic model. Antimicrobial Agents and Chemotherapy. 41(1). 7–12. 7 indexed citations

10.

Gilbert, Deborah, et al.. (1996). In-vitro interaction of azithromycin and fluoroquinolones against gram-positive and gram-negative bacteria. Clinical Microbiology and Infection. 1(3). 183–189. 3 indexed citations

11.

Firsov, Alexander A., et al.. (1996). Predictors of effect of ampicillin-sulbactam against TEM-1 beta-lactamase-producing Escherichia coli in an in vitro dynamic model: enzyme activity versus MIC. Antimicrobial Agents and Chemotherapy. 40(3). 734–738. 31 indexed citations

12.

Ai, Yunjun, Nancy A. Jenkins, Neal G. Copeland, et al.. (1995). Mouse galactokinase: isolation, characterization, and location on chromosome 11.. Genome Research. 5(1). 53–59. 14 indexed citations

13.

Gilbert, Deborah, et al.. (1994). Pharmacodynamics of piperacillin alone and in combination with tazobactam against piperacillin-resistant and -susceptible organisms in an in vitro model of infection. Antimicrobial Agents and Chemotherapy. 38(10). 2351–2356. 47 indexed citations

14.

McGrath, B J, C. Randall Marchbanks, Deborah Gilbert, & Michael N. Dudley. (1993). In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin, and tobramycin. Antimicrobial Agents and Chemotherapy. 37(8). 1723–1725. 22 indexed citations

15.

Barmada, Sami J., S J Kohlhepp, J. E. Leggett, R J Dworkin, & Deborah Gilbert. (1993). Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli. Antimicrobial Agents and Chemotherapy. 37(12). 2678–2683. 17 indexed citations

16.

Marchbanks, C. Randall, Deborah Gilbert, N J Robillard, et al.. (1993). Dose ranging and fractionation of intravenous ciprofloxacin against Pseudomonas aeruginosa and Staphylococcus aureus in an in vitro model of infection. Antimicrobial Agents and Chemotherapy. 37(9). 1756–1763. 50 indexed citations

17.

Dudley, Michael N., J. Blaser, Deborah Gilbert, Kenneth H. Mayer, & Stephen H. Zinner. (1991). Combination Therapy with Ciprofloxacin plus Azlocillin against Pseudomonas aeruginosa: Effect of Simultaneous versus Staggered Administration in an In Vitro Model of Infection. The Journal of Infectious Diseases. 164(3). 499–506. 32 indexed citations

18.

Zinner, Stephen H., et al.. (1988). Effect of dose and schedule on cefoperazone pharmacodynamics in an in Vitro model of infection in a neutropenic host. The American Journal of Medicine. 85(1). 56–58. 18 indexed citations

19.

Dudley, Michael N., et al.. (1986). Influence of medium and method on the in vitro susceptibility of Pseudomonas aeruginosa and other bacteria to ciprofloxacin and enoxacin. Antimicrobial Agents and Chemotherapy. 29(5). 927–929. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact